Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans
- PMID: 10632475
- DOI: 10.1055/s-2007-994962
Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans
Abstract
We report the effects of substitution with a virus-inactivated protein C (PC) concentrate in disseminated intravascular coagulation (DIC) in infants and children with meningococcal sepsis associated with purpura fulminans. It was a prospective open-label study. Eight pediatric and adolescent patients age 0.2 to 18.25 years with DIC associated with severe acquired PC deficiency (range 0.02 to 0.48 IU/mL; median, 0.22 IU/mL) in meningococcal septic shock and purpura fulminans were studied. Replacement therapy was initiated with a virus-inactivated PC concentrate with an initial intravenous bolus of 80 to 120 IU/kg followed by 50 IU/kg up to six times per day as an adjunctive therapeutic regimen to otherwise optimal intensive care treatment. After initial PC administration, plasma PC levels rose to normal ranges and were maintained under PC replacement therapy. Improving or even normalizing global hemostatic parameters were assessed in all patients. Markedly elevated plasminogen activator inhibitor type 1 (PAI-1) levels prior to treatment, reflecting a reduced fibrinolytic potential, decreased rapidly under PC substitution. Concomitantly improving signs of purpura fulminans reflected by decreasing size of skin lesions, demonstrated a restoring microcirculation. Six of the eight patients survived. One patient required limb amputation; two patients died because of multiorgan failure. Both presented with a severely low plasma PC activity of 0.02 IU/mL on admission to the hospital. No adverse effects were observed with the PC concentrate administration. It can be concluded that the administration of PC concentrate had a marked benefit on the deranged coagulation status of patients with purpura fulminans and meningococcal septicemia. Normalization or even partial correction of hemostasis as well as improvement of microcirculation accompanied by improving signs of purpura fulminans were demonstrated in all patients.
Similar articles
-
Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.Crit Care Med. 2003 Jun;31(6):1839-47. doi: 10.1097/01.CCM.0000072121.61120.D8. Crit Care Med. 2003. PMID: 12794428 Clinical Trial.
-
Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin).Vox Sang. 2006 May;90(4):294-301. doi: 10.1111/j.1423-0410.2006.00760.x. Vox Sang. 2006. PMID: 16635072
-
Replacement treatment with protein C in an 18-year-old man with meningococcal sepsis and purpura fulminans.Minerva Anestesiol. 2003 Sep;69(9):691-3, 693-5. Minerva Anestesiol. 2003. PMID: 14564239 English, Italian.
-
Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency.Semin Thromb Hemost. 1995;21(4):371-81. doi: 10.1055/s-2007-1000658. Semin Thromb Hemost. 1995. PMID: 8747700 Review.
-
[Use of protein C concentrate in critical conditions: clinical experience in pediatric patients with sepsis].Minerva Anestesiol. 2004 May;70(5):357-63. Minerva Anestesiol. 2004. PMID: 15181416 Review. Italian.
Cited by
-
Diagnostic Scores and Treatment Options for Acute Disseminated Intravascular Coagulation in Children.Cureus. 2021 Sep 3;13(9):e17682. doi: 10.7759/cureus.17682. eCollection 2021 Sep. Cureus. 2021. PMID: 34513536 Free PMC article. Review.
-
Antithrombin III (AT) and recombinant tissue plasminogen activator (R-TPA) used singly and in combination versus supportive care for treatment of endotoxin-induced disseminated intravascular coagulation (DIC) in the neonatal pig.Thromb J. 2006 May 18;4:7. doi: 10.1186/1477-9560-4-7. Thromb J. 2006. PMID: 16707024 Free PMC article.
-
Protein C Pathway in Paediatric and Neonatal Sepsis.Front Pediatr. 2022 Feb 2;9:562495. doi: 10.3389/fped.2021.562495. eCollection 2021. Front Pediatr. 2022. PMID: 35186813 Free PMC article. Review.
-
Protein C in adult patients with sepsis: from pathophysiology to monitoring and supplementation.J Anesth Analg Crit Care. 2025 Apr 14;5(1):21. doi: 10.1186/s44158-025-00243-0. J Anesth Analg Crit Care. 2025. PMID: 40229903 Free PMC article. Review.
-
An ADAM-10 dependent EPCR shedding links meningococcal interaction with endothelial cells to purpura fulminans.PLoS Pathog. 2018 Apr 9;14(4):e1006981. doi: 10.1371/journal.ppat.1006981. eCollection 2018 Apr. PLoS Pathog. 2018. PMID: 29630665 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous